Document:

Careview Communications, Inc. 8-K

 

Exhibit
10.13

EIGHTH
AMENDMENT TO MODIFICATION AGREEMENT

This
EIGHTH AMENDMENT TO MODIFICATION AGREEMENT (this “Amendment”) is made and entered into as of December
3, 2018 (the “Amendment Effective Date”), by and among CAREVIEW COMMUNICATIONS, INC., a Nevada corporation
(“Holdings”), CAREVIEW COMMUNICATIONS, INC., a Texas corporation and a wholly owned subsidiary of Holdings
(the “Borrower”), CAREVIEW OPERATIONS, L.L.C., a Texas limited liability company (the “Subsidiary
Guarantor”), and PDL INVESTMENT HOLDINGS, LLC (as assignee of PDL BioPharma, Inc.), a Delaware limited liability
company (both in its capacity as the lender (“Lender”) and in its capacity as Agent (solely in such
capacity as Agent, the “Agent”)) under the Credit Agreement (as defined below).

RECITALS

A.               

Reference is made to that certain Credit Agreement dated as of June 26, 2015, among Holdings, the Borrower, the Lender and the
Agent (as amended, supplemented or modified as of the date hereof (the “Credit Agreement”), including
pursuant to that certain First Amendment to Credit Agreement dated as of October 7, 2015, that certain Modification Agreement
dated as of February 2, 2018 (the “Modification Agreement”), that certain Second Amendment to Credit
Agreement dated as of February 23, 2018 (the “Second Amendment”), that certain Amendment to Modification
Agreement dated as of May 31, 2018 (the “First Modification Amendment”), that certain Second Amendment
to Modification Agreement dated as of June 14, 2018 (the “Second Modification Amendment”), that certain
Third Amendment to Modification Agreement dated as of June 28, 2018 (the “Third Modification Amendment”),
that certain Third Amendment to Credit Agreement dated as of July 13, 2018, that certain Fourth Amendment to Modification
Agreement dated as of August 31, 2018 (the “Fourth Modification Amendment”), that certain Fifth Amendment
to Modification Agreement dated as of September 28, 2018 (the “Fifth Modification Amendment”),
that certain Sixth Amendment to Modification Agreement dated as of November 12, 2018 (the “Sixth Modification Amendment”),
and that certain Seventh Amendment to Modification Agreement dated as of November 19, 2018 (the “Seventh Modification
Amendment”)); capitalized terms used and not defined in this Amendment shall have the meaning set forth in
the Credit Agreement.

B.                

Pursuant to the Modification Agreement, as amended by the Second Amendment, the parties agreed that the Borrower shall obtain
(i) at least $2,050,000 in net cash proceeds from the issuance of Capital Stock (other than Disqualified Stock) or Debt on
or prior to February 23, 2018 (which obligation Borrower satisfied by Holdings’ issuance of Debt pursuant to that certain
Eighth Amendment to Note and Warrant Purchase Agreement dated as of February 23, 2018) and (ii) an additional $3,000,000
in net cash proceeds from the issuance of Capital Stock (other than Disqualified Stock) or Debt on or prior to May 31, 2018
(resulting in aggregate net cash proceeds of at least $5,050,000).

C.                

Pursuant to the First Modification Amendment, as amended by the Second Modification Amendment, the Third Modification Amendment,
the Fourth Modification Amendment, the Fifth Modification Amendment, the Sixth Modification Amendment and the Seventh Modification
Amendment, the parties agreed, among other things, to provide that the Borrower shall satisfy its obligation to obtain financing
referenced in B. above by obtaining: (i) at least $2,050,000 in net cash proceeds from the issuance of Capital Stock (other
than Disqualified Capital Stock) or Debt on or prior to February 23, 2018; and (ii) an additional (A) $750,000 in net
cash proceeds from the issuance of Capital Stock (other than Disqualified Capital Stock) or Debt on or prior to July 13, 2018
and (B) $750,000 in net cash proceeds from the issuance of Capital Stock (other than Disqualified Capital Stock) or Debt
on or prior to December 3, 2018 (resulting in aggregate net cash proceeds of $3,550,000).

    	  

    	 

    

D.               

The parties wish to enter into this Amendment to extend the period referred to in C.(ii)(B) above from “December 3, 2018”
until December 17, 2018.

E.                

Pursuant to the Modification Agreement, as amended by the First Modification Amendment, the Fifth Modification Amendment, the
Sixth Modification Amendment and the Seventh Modification Amendment, the parties also agreed that the (i) Lender shall have a
right to terminate the Modification Period (as defined in the Modification Agreement) on July 31, 2018 and December 3, 2018 (with
each such date permitted to be extended by the Lender in its sole discretion), and (ii) the Liquidity covenant set forth in the
Credit Agreement would be reduced to $1,825,000 during the Modification Period.

F.                 

The parties also wish to enter into this Amendment to extend the date for Lender to terminate the Modification Period from December
3, 2018 until December 17, 2018, and to further reduce the Liquidity covenant during the Modification Period from $1,825,000
to $1,525,000.

NOW,
THEREFORE, in consideration of the above premises, and for other good and valuable consideration, the receipt and sufficiency
of which are hereby acknowledged, the parties hereby agree as follows:

Article
I.

AMENDMENTs TO MODIFICATION AGREEMENT

Upon
the Amendment Effective Date:

1.1             

Modification Period. Section 2 of the
Modification Agreement, as amended by the First Modification Amendment, the Fifth Modification Amendment, Sixth Modification Amendment
and Seventh Modification Amendment, is amended and restated in its entirety as follows:

“2.

Modification
Period. Subject to the terms and conditions set forth herein, so long as no Modification Termination Event (as defined below)
shall have occurred, each of the Agent and the Lender agrees that the occurrence and continuance of any of the Covered Events
shall not constitute Events of Default from the Effective Date through the earliest to occur of any Modification Termination Event
(the “Modification Period”) and, for the avoidance of doubt, that the Default Rate shall not apply during the Modification
Period. As used herein, “Modification Termination Event” shall mean the earliest to occur of: (a) the occurrence of
any Event of Default under any Loan Documents that does not constitute a Covered Event; (b) the occurrence of any Agreement Event
of Default (as defined below); (c) the Lender’s delivery to Holdings and the Borrower of a Lender Termination Notice (as
defined below); and (d) December 31, 2018, subject to the Lender’s right, in its sole discretion, to terminate the Modification
Period on July 31, 2018 and December 17, 2018 (with each such date permitted to be extended by the Lender in its sole
discretion). Notwithstanding any other provision of this Modification Agreement or any other Loan Document, all principal and
interest otherwise due to Lender through the end of the Modification Agreement shall be due and payable at the end of the Modification
Period and if not paid in full in Cash at that time shall bear interest at the Default Rate from and after the end of the Modification
Period.”

    	2 

    	 

    

1.2             

Deadline for Raising Monies. The first
sentence of Section 5(a) of the Modification Agreement, as previously amended by the Second Amendment, the First Modification
Amendment, the Second Modification Amendment, the Third Modification Amendment, the Fourth Modification Amendment, the Fifth Modification
Amendment, the Sixth Modification Amendment and the Seventh Modification Amendment, is amended and restated in its entirety as
follows:

“(a)

The Borrower shall obtain: (i) at least $2,050,000 in net cash proceeds from the issuance of Capital Stock (other than Disqualified
Capital Stock) or Debt on or prior to February 23, 2018; and (ii) an additional (A) $750,000 in net cash proceeds from
the issuance of Capital Stock (other than Disqualified Capital Stock) or Debt on or prior to July 13, 2018 and (B) $750,000
in net cash proceeds from the issuance of Capital Stock (other than Disqualified Capital Stock) or Debt on or prior to December
17, 2018 (resulting in aggregate net cash proceeds of $3,550,000); provided that all such Debt described in clauses (i) and
(ii) shall be subordinated to the Loans under the Credit Agreement on terms satisfactory to the Lender in its sole discretion.”

1.3

Liquidity. Section 5(b) of the Modification Agreement is amended and restated in its entirety as follows:

“(b)

The Borrower shall not suffer or permit Liquidity to be less than $1,525,000 at any time. For the avoidance of doubt, any breach
of the Liquidity covenant set forth in Section 7.16 of the Credit Agreement during the Modification Period shall not constitute
an Event of Default under the Credit Agreement, Agreement Event of Default or Modification Termination Event so long as Borrower
does not suffer or permit Liquidity to be less than $1,525,000 at any time.”

Article
II.

REPRESENTATIONS AND WARRANTIES

In
order to induce the Agent and the Lender to enter into this Amendment, each of Holdings, the Borrower and the Subsidiary Guarantor
hereby represents and warrants to the Agent and the Lender that as of the date hereof, both prior to and after giving effect to
this Amendment:

2.1             

Organization. Holdings is a corporation
validly existing and in good standing under the laws of the State of Nevada; the Borrower is a corporation validly existing and
in good standing under the laws of the State of Texas; and each other Loan Party and each of its Subsidiaries is duly organized,
validly existing and in good standing (as applicable) under the laws of the jurisdiction of its incorporation or organization.
Each Loan Party has all power and authority and all material governmental approvals required for the ownership and operation of
its properties and the conduct of its business as now conducted and as proposed to be conducted and is qualified to do business,
and is in good standing (as applicable), in every jurisdiction where, because of the nature of its activities or properties, such
qualification is required, except for such jurisdictions where the failure to so qualify could not reasonably be expected to have
a Material Adverse Effect.

    	3 

    	 

    

2.2             

Due Authorization. The execution, delivery
and performance of this Amendment, and the performance of its obligations under the Modification Agreement and Credit Agreement,
each as amended hereby, have been duly authorized by all necessary action on the part of each Loan Party that is a party hereto.

2.3             

No Conflict. The execution, delivery and
performance of this Amendment by each Loan Party that is a party hereto and the consummation of the transactions contemplated
hereby do not and will not (a) require any consent or approval of, or registration or filing with or any other action by, any
Governmental Authority (other than any consent or approval which has been obtained and is in full force and effect), (b) conflict
with (i) any provision of material Applicable Law, (ii) the charter, by-laws, limited liability company agreement, partnership
agreement or other organizational documents of any Loan Party or (iii) any material agreement, indenture, instrument or other
document, or any judgment, order or decree, which is binding upon any Loan Party or any of their respective properties or (c)
require, or result in, the creation or imposition of any Lien on any asset of Holdings, the Borrower or any other Loan Party (other
than Permitted Liens and Liens in favor of the Agent created pursuant to the Collateral Documents).

2.4             

Incorporation of Representations and Warranties
from Loan Documents. Each representation and warranty by each Loan Party that is a party hereto contained in the Modification
Agreement, the Credit Agreement or in any other Modification Document or Loan Document to which such Loan Party is a party is
true and correct in all material respects (without duplication of any materiality qualifier contained therein) as of the date
hereof (or as of a specific earlier date if such representation or warranty expressly relates to an earlier date).

2.5             

No Default. Both prior to and after giving
effect to this Amendment, no Default or Event of Default has occurred and is continuing, and no Default or Event of Default will
result from the execution and delivery of this Amendment and the consummation of the transactions contemplated herein.

2.6             

Validity; Binding Nature. This Amendment
has been duly executed by each Loan Party that is a party hereto, and each of (i) this Amendment, (ii) the Modification Agreement
as amended hereby and (iii) the Credit Agreement as amended hereby is the legal, valid and binding obligation of each Loan Party
that is a party hereto, enforceable against such Person in accordance with its terms, subject to bankruptcy, insolvency and similar
laws affecting the enforceability of creditors’ rights generally and to general principles of equity.

Article
III.

MISCELLANEOUS

3.1             

Modification and Loan Document. This Amendment
is a Modification Document and Loan Document executed pursuant to the Credit Agreement and shall (unless otherwise expressly indicated
therein) be construed, administered and applied in accordance with the terms and provisions of the Credit Agreement.

3.2             

Effect of Amendment. Except as expressly
set forth herein, this Amendment shall not by implication or otherwise limit, impair, constitute a waiver of, or otherwise affect,
the rights and remedies of the parties to the Credit Agreement and shall not alter, modify, amend or in any way affect any of
the terms or conditions contained therein, all of which are ratified and affirmed in all respects and shall continue in full force
and effect. Nothing herein shall be deemed to entitle any Loan Party to any future consent with respect to, or waiver, amendment,
modification or other change of, any of the terms or conditions contained in the Credit Agreement in similar or different circumstances.
Except as expressly stated herein, the Agent and the Lender reserve all rights, privileges and remedies under the Loan Documents.
All references in the Credit Agreement and the other Loan Documents to the Credit Agreement shall be deemed to be references to
the Credit Agreement as modified hereby.

3.3             

Reaffirmation. Each of Holdings, the Borrower
and the Subsidiary Guarantor hereby reaffirms its obligations under each Modification Document and Loan Document to which it is
a party. Each of Holdings, the Borrower and the Subsidiary Guarantor hereby further ratifies and reaffirms the validity and enforceability
of all of the liens and security interests heretofore granted, pursuant to and in connection with the Guarantee and Collateral
Agreement or any other Loan Document, to the Agent, as collateral security for the obligations under the Loan Documents in accordance
with their respective terms, and acknowledges that all of such liens and security interests, and all Collateral heretofore pledged
as security for such obligations, continue to be and remain collateral for such obligations from and after the date hereof.

3.4             

Fees and Expenses. The Borrower agrees
to pay within five Business Days of the Amendment Effective Date, by wire transfer of immediately available funds to an account
of the Agent designated in writing, reimbursement from the Borrower of all costs and expenses incurred by the Agent and the Lender
in connection with this Amendment, including any and all fees payable or owed to Gibson, Dunn & Crutcher LLP in connection
with the drafting, negotiation, and execution of this Amendment.

3.5             

Counterparts. This Amendment may be executed
by the parties hereto in several counterparts, each of which shall be deemed to be an original and all of which shall constitute
together but one and the same agreement. Delivery of an executed signature page of this Amendment by facsimile transmission or
electronic transmission shall be as effective as delivery of a manually executed counterpart hereof.

    	4 

    	 

    

3.6             

Construction; Captions. Each party hereto
hereby acknowledges that all parties hereto participated equally in the negotiation and drafting of this Amendment and that, accordingly,
no court construing this Amendment shall construe it more stringently against one party than against the other. The captions and
headings of this Amendment are for convenience of reference only and shall not affect the interpretation of this Amendment.

3.7             

Successors and Assigns. This Amendment
shall be binding upon and inure to the benefit of the parties hereto and their respective successors and assigns (as permitted
under the Credit Agreement).

3.8             

GOVERNING LAW. THIS AMENDMENT, THE RIGHTS
AND OBLIGATIONS OF THE PARTIES HERETO, AND ANY CLAIMS OR DISPUTES RELATING THERETO SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE
WITH THE INTERNAL LAWS OF THE STATE OF NEW YORK WITHOUT REGARD TO CONFLICT OF LAWS PRINCIPLES (OTHER THAN SECTION 5-1401 OF THE
NEW YORK GENERAL OBLIGATIONS LAW).

3.9             

Severability. The illegality or unenforceability
of any provision of this Amendment or any instrument or agreement required hereunder shall not in any way affect or impair the
legality or enforceability of the remaining provisions of this Amendment or any instrument or agreement required hereunder.

3.10         

Release of Claims. In consideration of
the Lender’s and Agent’s agreements contained in this Amendment, each of Holdings, the Borrower and the Subsidiary
Guarantor hereby releases and discharges the Lender and the Agent and their affiliates, subsidiaries, successors, assigns, directors,
officers, employees, agents, consultants and attorneys (each, a “Released Person”) of and from any and
all other claims, suits, actions, investigations, proceedings or demands, whether based in contract, tort, implied or express
warranty, strict liability, criminal or civil statute or common law of any kind or character, known or unknown, which Holdings,
the Borrower or the Subsidiary Guarantor ever had or now has against the Agent, any Lender or any other Released Person which
relates, directly or indirectly, to any acts or omissions of the Agent, any Lender or any other Released Person relating to the
Modification Agreement or Credit Agreement or any other Modification Document or Loan Document on or prior to the date hereof.

[Signature
page follows]

 

    	5 

    	 

    
IN
WITNESS WHEREOF, the parties hereto have caused this Amendment to be executed as of the date first above written.

 

	 	CAREVIEW
COMMUNICATIONS, INC.,

a
Nevada corporation,

as
Holdings

	 	 
	 	 
	 	By: 
	/s/ Steven G. Johnson  

	 	 
	Name: 
	Steven G. Johnson

	 	 
	Title:
	President and Chief Executive Officer

	 	 
	 	 
	 	CAREVIEW
COMMUNICATIONS, INC.,

a
Texas corporation,

as
Borrower

	 	 
	 	 
	 	By: 
	/s/ Steven G. Johnson  

	 	 
	Name: 
	Steven G. Johnson

	 	 
	Title:
	President and Chief Executive Officer

	 	 
	 	 
	 	CAREVIEW
OPERATIONS, L.L.C.,

a
Texas limited liability company,

as
Subsidiary Guarantor

	 	 
	 	 
	 	By: 
	/s/ Steven G. Johnson  

	 	 
	Name: 
	Steven G. Johnson

	 	 
	Title:
	President and Chief Executive Officer

 

[Signature Page to Eighth Amendment to Modification
Agreement]

 

    	  

    	 

    

 

IN
WITNESS WHEREOF, the parties hereto have caused this Amendment to be executed as of the date first above written.

 

	 	PDL
INVESTMENT HOLDINGS, LLC,

a
Delaware limited liability company,

as
Agent

	 	 
	 	 
	 	By: 
	/s/
                    Christopher Stone  

	 	 
	Name: 
	Christopher Stone

	 	 
	Title:
	CEO and Treasurer

	 	 
	 	 
	 	PDL
INVESTMENT HOLDINGS, LLC,

a
Delaware limited liability company,

as
Lender

	 	 
	 	 
	 	By:
         
	/s/
                    Christopher Stone  

	 	 
	Name: 
	Christopher Stone

	 	 
	Title:
	CEO and Treasurer

 

 

[Signature Page to Eighth Amendment to Modification
Agreement]Exhibit 10.1

 

AMENDMENT TO LIMITED FORBEARANCE AGREEMENT

 

This AMENDMENT TO LIMITED FORBEARANCE AGREEMENT is made as of December 5, 2018 (this “Amendment”), among Synergy Pharmaceuticals Inc., a Delaware corporation (“Borrower”), the Subsidiary Guarantors (as defined in the Loan Agreement referred to below) party hereto, the Lenders (as defined in the Loan Agreement referred to below), and CRG Servicing LLC, a Delaware limited liability company (“CRG Servicing”), as administrative agent and collateral agent for the Lenders (in such capacities, together with its successors and assigns, “Agent” and, collectively with Lenders, “CRG Parties”).

 

RECITALS

 

A.                                    Borrower, the Subsidiary Guarantors and the CRG Parties entered into that certain Limited Forbearance Agreement effective November 19, 2018 (the “Forbearance Agreement”).  Capitalized terms used herein without definition have the meanings assigned thereto in the Forbearance Agreement.

 

B.                                    Obligors and the CRG Parties desire to amend, among other things, the definition of “Forbearance Period” in Section 1(a) of the Forbearance Agreement subject to the terms hereof.

 

NOW, THEREFORE, for valuable consideration, the receipt and adequacy of which is hereby acknowledged, and in consideration of the premises and the mutual covenants contained herein, the parties hereto hereby agree as follows:

 

SECTION 1.

 

1.                                      Recitals.   The Recitals shall be construed as part of this Amendment.

 

2.                                      Extension of Forbearance Period.  The definition of “Forbearance Period” set forth in Section 1(a) of the Forbearance Agreement is hereby restated in its entirety to state as follows:

 

“Forbearance Period” means the period commencing on the date hereof and ending on the earliest to occur of (i) December 14, 2018 (11:59 p.m. Central time); (ii) the occurrence of any default or Event of Default under the Loan Agreement or the other Loan Documents, other than the Designated Defaults and the Liquidity Covenant Default; and (iii) in the event a petition in bankruptcy is filed by or against the Obligors, or any one of them, the date of such filing, in the event the Obligors fail to include within their first-day motions a motion for approval of debtor-in-possession financing and use of cash collateral acceptable to the CRG Parties.

 

3.                                      Amendment to Section 7 of the Forbearance Agreement.  Section 7(a)(ii) of the Forbearance Agreement is hereby amended and restated in its entirety to state as follows:

 

 

“(ii) no Default or Event of Default (other than the Designated Defaults and the Liquidity Covenant Default) has occurred or is continuing, or would result after giving effect hereto.”

 

SECTION 2.                                   Conditions to Effectiveness.

 

The effectiveness of this Amendment is expressly conditioned upon the satisfaction and delivery of each of the applicable conditions set forth below:

 

a)             Agent shall have received this Amendment duly executed and delivered by Obligors and CRG Parties.

 

b)             Obligor shall have paid or reimbursed Lenders for Lenders’ reasonable out of pocket costs and expenses incurred in connection with the Forbearance Agreement and this Amendment that have been invoiced at least one Business Day prior to the date hereof, including Lenders’ reasonable out of pocket legal fees and costs, pursuant to Section 13.03(a)(i)(z) of the Loan Agreement.

 

c)              The representations and warranties contained in Section 7 of the Forbearance Agreement (as amended by this Amendment) shall be true and correct on the date hereof.

 

d)             As a condition to the continued effectiveness of this Amendment, the Obligors covenant to deliver to CRG, no later than December 8, 2018, the following:

 

(i)                                     A list of all patents and patent applications created, owned and/or made by Borrower or the Subsidiary Guarantors since September 1, 2017; and

 

(ii)                                  A fully executed amendment to the short form intellectual property security agreement, substantially in the form attached hereto as Exhibit A.

 

SECTION 3.                                   Full Force and Effect.  Except as expressly modified by this Amendment, all terms and conditions of the Forbearance Agreement shall continue in full force and effect.

 

SECTION 4.                                   Miscellaneous.

 

(a)                                 Counterparts.  This Amendment may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument and any of the parties hereto may execute this Amendment by signing any such counterpart.

 

(b)                                 Loan Document.  This Amendment is a Loan Document.

 

(c)                                  Entire Agreement.  This Amendment, including all schedules and other documents attached hereto or incorporated by reference herein or delivered in connection herewith, constitutes the entire agreement of the signing parties with respect to the subject matter hereof and supersedes all other understandings, oral or written, with respect to the subject matter hereof.

 

2

 

(d)                                 Reviewed by Attorneys.  Each Obligor represents and warrants to CRG Parties that it (i) understands fully the terms of this Amendment and the consequences of the execution and delivery of this Amendment, (ii) has been afforded an opportunity to have this Amendment reviewed by, and to discuss this Amendment and the documents executed in connection herewith, with such attorneys and other persons and advisors as such Obligor may wish, and (iii) has entered into this Amendment and executed and delivered all documents in connection herewith of its own free will and accord and without threat, duress or other coercion of any kind by any Person.  The parties hereto acknowledge and agree that neither this Amendment nor any of the other documents executed pursuant hereto shall be construed more favorably in favor of one party over the other based upon which party drafted the same, it being acknowledged that all parties hereto contributed substantially to the negotiation and preparation of this Amendment and the other documents executed pursuant hereto or in connection herewith.

 

(e)                                  Further Assurances.  Each Obligor agrees to, and to cause any other Obligor to, take all further actions and execute all further documents as Agent may from time to time reasonably request to carry out the transactions contemplated by this Amendment and all other agreements executed and delivered in connection herewith.

 

[signature pages follow]

 

3

 

IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be duly executed and delivered as of the day and year first above written.

 

	
 
    	
BORROWER:
    
	
 
    	
 
    
	
 
    	
SYNERGY PHARMACEUTICALS INC.
    
	
 
    	
 
    
	
 
    	
By 
    	
/s/ Gary G. Gemignani
    
	
 
    	
 
    	
Name: 
    	
Gary G. Gemignani
    
	
 
    	
 
    	
Title:
    	
EVP, Chief Financial Officer
    
	
 
    	
 
    
	
 
    	
SUBSIDIARY GUARANTORS:
    
	
 
    	
 
    
	
 
    	
SYNERGY ADVANCED PHARMACEUTICALS, INC.
    
	
 
    	
 
    
	
 
    	
By 
    	
/s/ Gary G. Gemignani
    
	
 
    	
 
    	
Name: 
    	
Gary G. Gemignani
    
	
 
    	
 
    	
Title:
    	
EVP, Chief Financial Officer
    

 

1

 

	
ADMINISTRATIVE AGENT:
    	
 
    
	
 
    	
 
    
	
CRG SERVICING LLC
    	
 
    
	
 
    	
 
    
	
By 
    	
/s/ Nathan Hukill
    	
 
    
	
 
    	
Nathan Hukill
    	
 
    
	
 
    	
President
    	
 
    
	
 
    	
 
    
	
LENDERS:
    	
 
    
	
 
    	
 
    
	
CRG PARTNERS   III—PARALLEL FUND “A” L.P.
    
	
By
    	
CRG PARTNERS III—PARALLEL FUND “A” GP L.P.,   its General Partner
    
	
 
    	
By 
    	
CRG PARTNERS III GP LLC, its General Partner
    	
 
    
	
 
    	
 
    	
 
    	
 
    
	
 
    	
By 
    	
/s/ Nathan Hukill
    	
 
    
	
 
    	
 
    	
Nathan Hukill
    	
 
    
	
 
    	
 
    	
Authorized Signatory
    	
 
    
	
 
    	
 
    
	
CRG PARTNERS III   (CAYMAN) UNLEV AIV I L.P.
    
	
By
    	
CRG PARTNERS III (CAYMAN) GP L.P., its   General Partner
    
	
 
    	
By CRG PARTNERS III GP LLC, its General   Partner
    	
 
    
	
 
    	
 
    
	
 
    	
By 
    	
/s/ Nathan Hukill
    	
 
    
	
 
    	
 
    	
Nathan Hukill
    	
 
    
	
 
    	
 
    	
Authorized Signatory
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
Witness:
    	
/s/ Nicole Nesson
    	
 
    
	
 
    	
Name: Nicole Nesson
    	
 
    
	
 
    	
 
    
	
CRG ISSUER 2017-1
    	
 
    
	
By
    	
CRG SERVICING LLC, acting by power of   attorney
    
	
 
    	
 
    
	
By 
    	
/s/ Nathan Hukill
    	
 
    
	
 
    	
Nathan Hukill
    	
 
    
	
 
    	
Authorized Signatory
    	
 
    
					

 

2

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00289-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00289-of-00352.parquet"}]]